Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

179 ta ish

Ish: Exploring Potential Mechanisms for Epilepsy After <scp>mRNA COVID</scp> ‐19 Vaccination: An Extremely Rare Side‐Effect

  1. Extrapulmonary manifestations of COVID-19

    Aakriti Gupta, Mahesh V. Madhavan, Kartik Sehgal +26

    Sharh maqola20205 iqtibos
    ABI

  2. Decoding virulence and resistance in Klebsiella pneumoniae: Pharmacological insights, immunological dynamics, and in silico therapeutic strategies

    Ali Alishvandi, Maryam Barancheshemeh, Faezeh Firuzpour +3

    Sharh maqola20255 iqtibos
    ABI

  3. Development of a candidate mRNA vaccine based on Multi-Peptide targeting VP4 of rotavirus A: an immunoinformatics and molecular dynamics approach

    Cena Aram, Leila Karami, Mohammad Mehdi Ranjbar

    Maqola20255 iqtibos
    ABI

  4. Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats

    Yutao Lou, Feifeng Song, Mengting Cheng +8

    Maqola20234 iqtibos
    ABI

  5. Nanocarriers in glioblastoma treatment: a neuroimmunological perspective

    Faezeh Firuzpour, Kiarash Saleki, Cena Aram +1

    Sharh maqola20244 iqtibos
    ABI

  6. Clinical and immunological features of severe and moderate coronavirus disease 2019

    Guang Chen, Di Wu, Wei Guo +17

    Maqola20203 iqtibos
    ABI

  7. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement

    Rumiana Tenchov, Robert E. Bird, Allison Curtze +1

    Sharh maqola20213 iqtibos
    ABI

  8. Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy

    Annamaria Vezzani, Silvia Balosso, Teresa Ravizza

    Sharh maqola20193 iqtibos
    ABI

  9. Meningitis after COVID-19 vaccination, a systematic review of case reports and case series

    Amirhomayoun Atefi, Aref Ghanaatpisheh, Amirhosein Ghasemi +6

    Sharh maqola20243 iqtibos
    ABI

  10. mRNA vaccines for infectious diseases: principles, delivery and clinical translation

    Namit Chaudhary, Drew Weissman, Kathryn A. Whitehead

    Sharh maqola20213 iqtibos
    ABI

  11. IL-6 in Inflammation, Immunity, and Disease

    Toshio Tanaka, Masashi Narazaki, T Kishimoto

    Sharh maqola20143 iqtibos
    ABI

  12. SARS-CoV-2 viral load is associated with increased disease severity and mortality

    Jesse Fajnzylber, James Regan, Kendyll Coxen +97

    Maqola20202 iqtibos
    ABI

  13. Development and validation of an automatic machine learning model to predict abnormal increase of transaminase in valproic acid-treated epilepsy

    Hongying Ma, Sihui Huang, Fengxin Li +7

    Maqola20242 iqtibos
    ABI

  14. Evolution of antibody immunity to SARS-CoV-2

    Christian Gaebler, Zijun Wang, Julio C. C. Lorenzi +39

    Maqola20212 iqtibos
    ABI

  15. Direct Gene Transfer into Mouse Muscle in Vivo

    Jon A. Wolff, Robert W. Malone, Phillip Williams +4

    Maqola19902 iqtibos
    ABI

  16. Tumor Necrosis Factor Alpha: A Link between Neuroinflammation and Excitotoxicity

    Gabriel Olmos, Jerònia Lladó

    Sharh maqola20142 iqtibos
    ABI

  17. Multiple Sclerosis Pathology

    Hans Lassmann

    Sharh maqola20182 iqtibos
    ABI

  18. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

    David Adams, Alejandra González‐Duarte, William O’Riordan +33

    Maqola20182 iqtibos
    ABI

  19. Detection of SARS-CoV-2 in Different Types of Clinical Specimens

    Wenling Wang, Yanli Xu, Ruqin Gao +4

    Maqola20202 iqtibos
    ABI

  20. Virological assessment of hospitalized patients with COVID-2019

    Roman Wölfel, Victor M. Corman, Wolfgang Guggemos +15

    Maqola20202 iqtibos
    ABI

  21. Acidity enhancement of α‐carbon of beta diketones via hydroxyl substituents: A density functional theory study

    Mona Rahimi, Alireza Fattahi

    Maqola20202 iqtibos
    ABI

  22. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases

    Devon E. McMahon, Erin Amerson, Misha Rosenbach +11

    Maqola20212 iqtibos
    ABI

  23. Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report

    Luca Spiro Santovito, Graziano Pinna

    Boshqa20212 iqtibos
    ABI

  24. Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions

    Marisa McGinley, Jeffrey A. Cohen

    Sharh maqola20212 iqtibos
    ABI

  25. The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

    Sonia Ndeupen, Zhen Qin, Sonya Jacobsen +3

    Maqola20212 iqtibos
    ABI